Latest Breaking News On - Athos service gmbh - Page 1 : comparemela.com

iOmx Therapeutics Raises EUR 65M in Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

New zealand generalNew zealandApollon papadimitriouPhilipp beckhoveNisit khandelwalAthos service gmbGerman cancer research centerOmx therapeuticsAthos service gmbhWellington partnersSofinnova partners

iOmx Therapeutics AG: iOmx Therapeutics Raises EUR 65 million in Series B Round

Financing round with top-tier life science venture capitalists, led by Athos Service and MIG Capital, joined by existing shareholdersThe new funds will be used to advance iOmx' lead programs IMT-07 and

New zealand generalNew zealandFrance generalUnited statesCity ofUnited kingdomNoord hollandApollon papadimitriouKatja arnoldNisit khandelwalShaun brownGerald moellerOxford immunotecKostenloser wertpapierhandelPhilipp beckhoveMatthias kromayer

iOmx Therapeutics Raises EUR 65 million in Series B Round

iOmx Therapeutics Raises EUR 65 million in Series B Round
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandFrance generalUnited statesCity ofUnited kingdomNoord hollandApollon papadimitriouKatja arnoldNisit khandelwalShaun brownGerald moellerOxford immunotecPhilipp beckhoveMatthias kromayerMc services

Merck KGgA venture arm bets on next generation cancer therapeutics player

M Ventures, the strategic, corporate venture capital arm of Merck KGgA, continues to fund iOmx Therapeutics AG, a company developing cancer therapeutics based on next generation immune checkpoint targets.

New zealand generalNew zealandPhilipp beckhoveNisit khandelwalGerman cancer research centreAthos service gmbAthos service gmbhBesidesm venturesWellington partnersBio developmentsCheckpoint inhibitorMerck kgaa

iOmx Therapeutics Raises EUR 65 million in Series B Round

iOmx Therapeutics Raises EUR 65 million in Series B Round
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.